TNBC represents a highly aggressive subtype of breast cancer, distinguished by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. This evidence concerns the gene PGR and breast carcinoma.